IDH2 and central nervous system cancer: This was confirmed by the results of an imaging study in glioma patients [11] using simultaneous pH- and oxygen-sensitive molecular magnetic resonance imaging (MRI), which suggest that mutation of the IDH gene is associated with lower tumor acidity and lower vascular hypoxia.